Geisinger Implementation |
Hearing Loss |
Geisinger |
Case, Control |
336 |
6,479 |
|
|
Geisinger caMRSA Implementation |
caMRSA |
Geisinger |
Case, Control |
25 |
25 |
96%, 100% |
96% |
MGB |
Type 1 Diabetes |
|
Case, Control |
|
|
|
|
Marshfield Venous Thromboembolism implementation |
Venous Thromboembolism (VTE) |
Marshfield Clinic Research Foundation |
Case, Control |
50 |
49 |
98%, 100% |
|
NU depression data |
Depression |
Northwestern University |
Case, Control |
|
|
|
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
GH/UW Implementation |
Appendicitis |
|
Case, Control |
0 |
1,761 |
|
|
Marshfield Implementation |
Pneumonia- VUMC eMERGE v5.1 |
Marshfield Clinic Research Institute |
Case, Control |
|
|
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
Mayo clinic hearing loss implementation |
Hearing Loss |
Mayo Clinic |
Case, Control |
|
|
|
|
Vanderbilt Implementation of caMRSA |
caMRSA |
Vanderbilt University |
Case, Control |
262 |
2,313 |
|
|
NU T1DM PRS implementation |
Type 1 Diabetes |
Northwestern University |
Case, Control |
63 |
3,632 |
|
|
Venous Thromboembolism Implementation - Columbia |
Venous Thromboembolism (VTE) |
Columbia University |
Case, Control |
419 |
2,574 |
|
|
CHOP eMERGE III |
Migraine |
CHOP |
Case, Control |
|
|
|
|
Columbia Depression Implementation |
Depression |
Columbia University Medical Center |
Case, Control |
|
|
|
|
VU E3 implementation |
Clostridium Difficile Colitis |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
NU eMERGE pneumonia data |
Pneumonia- VUMC eMERGE v5.1 |
Northwestern University |
Case, Control |
|
|
|
|
Mayo CAAD cases and controls |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo |
Case, Control |
13 |
|
100% |
71% |
KPWA UW Hearing Loss |
Hearing Loss |
|
Case, Control |
2,403 |
1,787 |
|
|
caMRSA Implementation - Columbia |
caMRSA |
Columbia University |
Case, Control |
4 |
2,225 |
|
|
Implementation of NAFLD by VUMC |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
VUMC |
Case, Control |
677 |
15,878 |
|
|
VUMC_T1DM |
Type 1 Diabetes |
VUMC |
Case, Control |
|
|
|
|
Vanderbilt Zoster Implementation |
Herpes Zoster |
Vanderbilt University |
Case, Control |
|
|
96%, 100% |
|
Mayo Depression Algorithm Implementation |
Depression |
Mayo Clinic |
Case, Control |
|
|
|
|
Mayo Clinic eMERGE III Implementation |
Clostridium Difficile Colitis |
Mayo Clinic |
Case, Control |
103 |
4,494 |
|
|